A02 - Sole Source Justification under FAR 13_HT942525R0028_REDACTED.pdf

This document is a Sole Source Justification and Approval form under FAR 13.501 for the U.S. Army Medical Research Acquisition Activity (USAMRAA). The document justifies a sole source contract with Aptagen, LLC for generating two Deoxyribonucleic Acid (DNA) Aptamer Libraries per year, with each library containing ~1,000-10,000 targeted aptamers. The specific requirement is to develop broad-spectrum DNA aptamers capable of neutralizing toxins, with libraries that can target four to six viral targets.

Aptagen, LLC was identified as the only viable source after market research in September and October 2024, which examined three potential sources. The contract will be funded using FY25 Defense Health Program Research, Development, Test and Evaluation (RDT&E) funding. The performance period is twelve months with two optional twelve-month periods and one optional six-month extension. The justification notes that USAMRIID lacks personnel with the technical knowledge to develop these specific libraries, necessitating external support. A Notice of Intent to award a sole source contract will be posted on www.sam.gov for 15 days to allow potential capability statements.